Cargando…
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
Duchenne muscular dystrophy (DMD) is a muscle degenerating disease caused by dystrophin deficiency, for which therapeutic options are limited. To facilitate drug development, it is desirable to develop in vitro disease models that enable the evaluation of DMD declines in contractile performance. Her...
Autores principales: | Uchimura, Tomoya, Asano, Toshifumi, Nakata, Takao, Hotta, Akitsu, Sakurai, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233665/ https://www.ncbi.nlm.nih.gov/pubmed/34195678 http://dx.doi.org/10.1016/j.xcrm.2021.100298 |
Ejemplares similares
-
Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy
por: Yoshioka, Kantaro, et al.
Publicado: (2021) -
Orai1–STIM1 Regulates Increased Ca(2+) Mobilization, Leading to Contractile Duchenne Muscular Dystrophy Phenotypes in Patient-Derived Induced Pluripotent Stem Cells
por: Uchimura, Tomoya, et al.
Publicado: (2021) -
Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs
por: Kawada, Ryu, et al.
Publicado: (2023) -
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015) -
A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4
por: Sasaki-Honda, Mitsuru, et al.
Publicado: (2018)